resveratrol has been researched along with ciprofloxacin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 3 (75.00) | 2.80 |
Authors | Studies |
---|---|
Giang, NTK; Huong, DT; Quyen, TH; Thanh, ND; Toan, VN | 1 |
Andrés-Bilbao, M; Belmonte-Reche, E; Cebrián, R; de Paz, MV; Kuipers, OP; Li, Q; Lucas, R; Morales, JC; Peñalver, P | 1 |
Bezmaternykh, KV; Oktyabrsky, ON; Smirnova, GV; Tyulenev, AV | 1 |
Rosman, CWK; Sjollema, J; van der Mei, HC | 1 |
1 review(s) available for resveratrol and ciprofloxacin
Article | Year |
---|---|
Chemically Tuning Resveratrol for the Effective Killing of Gram-Positive Pathogens.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Resveratrol | 2022 |
3 other study(ies) available for resveratrol and ciprofloxacin
Article | Year |
---|---|
Synthesis and evaluation of in vivo antioxidant, in vitro antibacterial, MRSA and antifungal activity of novel substituted isatin N-(2,3,4,6-tetra-O-acetyl-β-d-glucopyranosyl)thiosemicarbazones.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antioxidants; Cell Line, Tumor; Chemistry Techniques, Synthetic; Drug Evaluation, Preclinical; Isatin; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Rats; Rats, Wistar; Structure-Activity Relationship; Thiosemicarbazones | 2016 |
Effect of resveratrol and quercetin on the susceptibility of Escherichia coli to antibiotics.
Topics: Anti-Bacterial Agents; Antioxidants; beta-Galactosidase; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Kanamycin; Oxidative Stress; Plant Extracts; Polyphenols; Quercetin; Resveratrol; Streptomycin; Stress, Physiological | 2020 |
Influence of sub-inhibitory concentrations of antimicrobials on micrococcal nuclease and biofilm formation in Staphylococcus aureus.
Topics: Anti-Infective Agents; Biofilms; Ciprofloxacin; Doxycycline; Erythromycin; Gentamicins; Micrococcal Nuclease; Polysaccharides, Bacterial; Resveratrol; Staphylococcus aureus; Stem Cells; Vancomycin | 2021 |